Concomitant KRAS and BRAF mutations in colorectal cancer

被引：35

作者：

Midthun, Lauren ^{[1
]}

Shaheen, Shagufta ^{[2
]}

Deisch, Jeremy ^{[3
]}

Senthil, Maheswari ^{[4
]}

Tsai, James ^{[5
]}

Hsueh, Chung-Tsen ^{[5
]}

机构：

[1] Loma Linda Univ, Dept Internal Med, Loma Linda, CA 92354 USA

[2] Stanford Med Ctr, Div Oncol, Stanford, CA USA

[3] Loma Linda Univ, Dept Pathol & Human Anat, Loma Linda, CA 92354 USA

[4] Loma Linda Univ, Dept Surg, Loma Linda, CA 92354 USA

[5] Loma Linda Univ, Div Med Oncol & Hematol, Dept Internal Med, 11175 Campus St,CSP 11015, Loma Linda, CA 92354 USA

来源：

JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2019年 / 10卷 / 03期

关键词：

BRAF; KRAS; colorectal cancer (CRC); SURVIVAL;

D O I：

10.21037/jgo.2019.01.10

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BRAF and KRAS are two key oncogenes in the RAS/RAF/MEK/MAP- kinase signaling pathway. While previously considered mutually exclusive, concomitant mutations in both KRAS and BRAF genes have been identified in colorectal cancer (CRC). The clinical outcome of these patients remains undetermined. We present the clinical course of two patients with CRC harboring mutations at codon 12 of KRAS and BRAF non-V600E mutations. More research is needed to determine the clinical- pathological effect of these simultaneous mutations of KRAS and BRAF in CRC on disease course and treatment

引用

页码：577 / 581

页数：5

共 50 条

[31] Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer
Seth, R.
Crook, S.
Ibrahem, S.
Fadhil, W.
Jackson, D.
Ilyas, M.
GUT, 2009, 58 (09) : 1234 - 1241
[32] Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer
Licar, Alenka
Cerkovnik, Petra
Novakovic, Srdjan
MEDICAL ONCOLOGY, 2011, 28 (04) : 1048 - 1053
[33] Intratumoral heterogeneity of KRAS and BRAF mutations in primary colorectal cancer and corresponding metastases
Zlobec, I.
Bihl, M.
Foerster, A.
Rufle, A.
Lugli, A.
VIRCHOWS ARCHIV, 2011, 459 : S318 - S318
[34] Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations
Li, Wenbin
Qiu, Tian
Ling, Yun
Guo, Lei
Li, Lin
Ying, Jianming
ONCOTARGET, 2015, 6 (37) : 39607 - 39613
[35] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
Murarasu, Daniela
Puiu, Liliana
Mihalcea, Corina
Cinca, Sabin
Simion, Laurentiu
JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92
[36] Changing incidence of BRAF and KRAS mutations in colorectal carcinoma
Bettington, M.
Brown, I.
Walker, N.
Rosty, C.
Clouston, A.
Pearson, S-A
Mckeone, D.
Leggett, B.
Whitehall, V.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 18 - 19
[37] Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Woolley, Connor E.
Domingo, Enric
Fernandez-Tajes, Juan
Pennel, Kathryn A. F.
Roxburgh, Patricia
Edwards, Joanne
Richman, Susan D.
Maughan, Tim S.
Kerr, David J.
Soriano, Ignacio
Tomlinson, Ian P. M.
MOLECULAR CANCER RESEARCH, 2025, 23 (04) : 300 - 312
[38] KRAS, BRAF and PIK3CA mutations in human colorectal cancer: Relationship with metastatic colorectal cancer
Li, Hong-Tao
Lu, Yuan-Yuan
An, Yan-Xin
Wang, Xin
Zhao, Qing-Chuan
ONCOLOGY REPORTS, 2011, 25 (06) : 1691 - 1697
[39] Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report
Iaccarino, Antonino
Pisapia, Pasquale
De Felice, Marco
Pepe, Francesco
Gragnano, Gianluca
De Luca, Caterina
Ianniello, Giovanni
Malapelle, Umberto
JOURNAL OF MOLECULAR PATHOLOGY, 2020, 1 (01): : 36 - 42
[40] KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population
Hao, Yi-Xin
Li, Yong-Mei
Ye, Ming
Guo, Yan-Yan
Li, Qiu-Wen
Peng, Xiu-Mei
Wang, Qi
Zhang, Shu-Fang
Zhao, Hui-Xia
Zhang, He
Li, Guang-Hui
Zhu, Jian-Hua
Xiao, Wen-Hua
ONCOLOGY LETTERS, 2017, 13 (05) : 3608 - 3616

← 1 2 3 4 5 →